A new male contraceptive is showing promising results in the early stages of human clinical trials, meaning it could launch a new era of reproductive technologies. “I think we as a society, especially ...

ADAM is the first hydrogel designed to occlude sperm passage through the vas deferens for a predefined period, degrading without intervention and thus offering a non-permanent contraceptive option for ...

ADAM™ is a water-soluble, biocompatible, and non-permanent hydrogel that is implanted into the vas deferens where it blocks sperm transport, resulting in azoospermia (no sperm in the ejaculate). ADAM™ ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience.View full ...

A male contraceptive gel named ADAM, injected into the vas deferens, shows significant promise in blocking sperm. The gel can reduce sperm counts by 99–100%, as seen in early clinical trials conducted ...

In 2016, a two-hormone birth control method for men made headlines. The injection showed promise, but Stage II trial was stopped after an independent review panel found the drug had “too many side ...

CHARLOTTESVILLE, VIRGINIA, UNITED STATES, November 2, 2023 / EINPresswire.com / -- Contraline, a clinical-stage medical device company announced the successful launch of two new sites in Australia for ...